INTERNATIONAL PATENT: RIGERNA THERAPEUTICS (SUZHOU) CO. LTD., 苏州炫景生物科技有限公司 FILES APPLICATION FOR "DOUBLE-STRANDED OLIGONUCLEOTIDE CONTAINING TERMINAL NUCLEOTIDE MODIFICATION AND USE THEREOF FOR INHIBITING AGT GENE EXPRESSION"

Posted On: 2026-05-03

GENEVA, May 3 -- RIGERNA THERAPEUTICS (SUZHOU) CO. LTD. (Room 702, Building B2, Phase I, Biomedical Industrial Park No. 218, Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215128), 苏州炫景生物科技有限公司 (中国江苏省苏州市中国（江苏）自由贸易试验区苏州片区苏州工业园区星湖街218号生物医药产业园一期B2栋702室) filed a patent application (PCT/CN2024/132149) for "DOUBLE-STRANDED OLIGONUCLEOTIDE CON...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: RIGERNA THERAPEUTICS (SUZHOU) CO. LTD., 苏州炫景生物科技有限公司 FILES APPLICATION FOR "DOUBLE-STRANDED OLIGONUCLEOTIDE CONTAINING TERMINAL NUCLEOTIDE MODIFICATION AND USE THEREOF FOR INHIBITING AGT GENE EXPRESSION"